Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia-specific basic symptoms. A successful replication

R Mass1, S Weigel, S Schneider

  • 1Universitäts-Krankenhaus Eppendorf, Klinik für Psychiatrie und Psychotherapie, Hamburg, Deutschland.

Psychopathology
|June 24, 1998
PubMed
Summary

The Frankfurt Complaint Questionnaire-Schizophrenia (FCQ-S) scale shows diagnostic sensitivity for schizophrenia. The Frankfurt Complaint Questionnaire-Alcoholism (FCQ-A) scale did not differentiate groups but correlated with alcoholism markers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Expression, identification and experience of emotions in mental diseases. An overview].

Der Nervenarzt·2013
Same author

[Prospective description of the course of psychopathological symptoms in schizophrenia: evaluation of the short form of the Eppendorf Schizophrenia Inventory].

Der Nervenarzt·2012
Same author

[Evaluation of subjective experience of cognitive deficit in patients with schizophrenia using the Eppendorf Schizophrenia Inventory].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2006
Same author

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

European psychiatry : the journal of the Association of European Psychiatrists·2004
Same author

[Eppendorf Schizophrenia Inventory (ESI) vs. Frankfurt Complaint Questionnaire (FCQ). Direct comparison in a clinical trial].

Der Nervenarzt·2004
Same author

[Identification of possible cognizance parameters of "mimic disintegration" in schizophrenia using facial electromyography].

Der Nervenarzt·2004

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Psychometrics

Background:

  • The Frankfurt Complaint Questionnaire (FCQ) has demonstrated a lack of diagnostic specificity in prior research.
  • Two novel subscales, FCQ-S (for schizophrenia) and FCQ-A (for alcoholism), were developed in a previous study.
  • Replicating the diagnostic sensitivity of these new subscales is crucial for their clinical utility.

Purpose of the Study:

  • To validate the diagnostic sensitivity of the FCQ-S and FCQ-A subscales.
  • To assess the ability of these subscales to differentiate between patient groups with distinct psychiatric conditions.

Main Methods:

  • The study included four groups: schizophrenics with marked negative symptoms (n=25), schizophrenics with mild/no negative symptoms (n=25), alcoholics (n=25), and obsessive-compulsive disorder patients (n=15).

Related Experiment Videos

  • Participants were assessed using the original FCQ subscales and total score, alongside the newly developed FCQ-S and FCQ-A subscales.
  • Statistical analyses were performed to compare scores across the different patient groups.

    • Main Results:

    • The original FCQ subscales and total score did not yield significant differences between the groups.
    • The FCQ-S subscale demonstrated significantly higher scores in both schizophrenic groups compared to the alcoholic and OCD groups.
    • The FCQ-A subscale did not differentiate between the patient groups but showed a significant correlation with established alcoholism markers.

    Conclusions:

    • The FCQ-S subscale shows promising diagnostic sensitivity for identifying schizophrenia, even in the presence of varying negative symptom severity.
    • The FCQ-A subscale requires further refinement as it did not reliably distinguish alcoholics from other patient groups in this study.
    • These findings support the potential utility of the FCQ-S for schizophrenia screening while highlighting the need for further validation of the FCQ-A.